NCT01450761 2020-07-08
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Bristol-Myers Squibb
Phase 3 Completed
Bristol-Myers Squibb
University College, London
National Cancer Institute (NCI)
Teva Branded Pharmaceutical Products R&D, Inc.